These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4113518)

  • 21. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
    Björkholm M; Askergren J; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
    Ferrari S; Foggi CM; Serafini NA
    Ann Ist Carlo Forlanini; 1968; 28(3):292-309. PubMed ID: 4903142
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.
    Rühl H; Vogt W; Bochert G; Schmidt S; Schaoua H; Moelle R
    Clin Exp Immunol; 1974 Jul; 17(3):407-15. PubMed ID: 4468860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera.
    Brochier J; Roitt IM; Festenstein H
    Eur J Immunol; 1974 Nov; 4(11):709-15. PubMed ID: 4279178
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunologic defects in Hodgkin's disease].
    De Sanctis C; Fabris C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1969 Sep; 21(38):1743-52. PubMed ID: 5362709
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nonspecific immunologic response in Hodgkin's disease].
    Rytwiński K; Schneiberg K; Szelc S; Kołosza Z; Tabeńska J
    Nowotwory; 1981; 31(3-4):181-90. PubMed ID: 6979738
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte response to phytohemagglutinin in Hodgkin's disease.
    Han T; Sokal JE
    Am J Med; 1970 Jun; 48(6):728-34. PubMed ID: 5420559
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunological competence in Hodgkin's disease].
    Lang JM
    Pathol Biol (Paris); 1973 Mar; 21(3):285-97. PubMed ID: 4145143
    [No Abstract]   [Full Text] [Related]  

  • 30. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte function in patients with Hodgkin's disease.
    Rühl H; Vogt W; Rühl U
    G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alteration of PHA stimulation and of cytochemical behaviour of lymphocytes from patients with Hodgkin's disease and bronchogenic carcinoma induced by 60Co radiotherapy (author's transl)].
    Krüsmann WF; Slanina J; Hennekeuser HH; Wahren C; Scholz R; Vorwerck H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 81(2):119-34. PubMed ID: 4277771
    [No Abstract]   [Full Text] [Related]  

  • 34. Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer.
    Sutherland RM; Inch WR; McCredie JA
    Cancer; 1971 Mar; 27(3):574-8. PubMed ID: 5279329
    [No Abstract]   [Full Text] [Related]  

  • 35. Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease.
    Richens ER; Williams MJ; Gough KR; Ancill RJ
    Gut; 1974 Jan; 15(1):24-8. PubMed ID: 4274413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of repeated and prolonged stimulation on the PHA-response of lymphocytes in Hodgkin's disease.
    Ippoliti G; Marini G; Ascari E; Casirola G
    Acta Haematol; 1974; 51(5):266-9. PubMed ID: 4209031
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
    Fabris C; De Sanctis C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):190-3. PubMed ID: 5574421
    [No Abstract]   [Full Text] [Related]  

  • 38. The in vitro response of peripheral blood lymphocytes from patients with Wiskott-Aldrich syndrome.
    Marinkovich VA
    Clin Allergy; 1972 Mar; 2(1):69-78. PubMed ID: 4275189
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.
    Björkholm M; Holm G; Mellstedt H; Pettersson D
    Clin Exp Immunol; 1975 Dec; 22(3):373-7. PubMed ID: 131665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Antigenic" disparity between cultured lymphoid cells and autologous lymphocytes.
    Han T; Sokal JE; Moore GE
    Am J Med; 1972 Oct; 53(4):437-45. PubMed ID: 4263184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.